Abstract
In this work, we present a fully automatic computer-aided diagnosis method for the early diagnosis of the Alzheimer’s disease. We study the distance between classes (labelled as normal controls and possible Alzheimer’s disease) calculated in 116 regions of the brain using the Welchs’s t-test. We select the regions with highest Welchs’s t-test value as features to perform classification. Furthermore, we also study the less discriminative region according to the t-test (regions with lowest t-test absolute values) in order to use them as reference. We show that the mean and standard deviation of the intensity values in these two regions, the less and most discriminative according to the Welch’s ttest, can be combined as a vector. The modulus and phase of this vector reveal statistical differences between groups which can be used to improve the classification task. We show how they can be used as input for a support vector machine classifier. The proposed methodology is tested in a SPECT brain database of 70 SPECT brain images yielding an accuracy up to 91.5% for a wide range of selected voxels.
Keywords: Computer aided diagnosis, feature extraction and selection, SPECT brain imaging, support vector machines.
Current Alzheimer Research
Title:An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease
Volume: 13 Issue: 7
Author(s): D. Salas-Gonzalez, F. Segovia, F. J. Martínez-Murcia, E. W. Lang, J. M. Gorriz and J. Ramırez
Affiliation:
Keywords: Computer aided diagnosis, feature extraction and selection, SPECT brain imaging, support vector machines.
Abstract: In this work, we present a fully automatic computer-aided diagnosis method for the early diagnosis of the Alzheimer’s disease. We study the distance between classes (labelled as normal controls and possible Alzheimer’s disease) calculated in 116 regions of the brain using the Welchs’s t-test. We select the regions with highest Welchs’s t-test value as features to perform classification. Furthermore, we also study the less discriminative region according to the t-test (regions with lowest t-test absolute values) in order to use them as reference. We show that the mean and standard deviation of the intensity values in these two regions, the less and most discriminative according to the Welch’s ttest, can be combined as a vector. The modulus and phase of this vector reveal statistical differences between groups which can be used to improve the classification task. We show how they can be used as input for a support vector machine classifier. The proposed methodology is tested in a SPECT brain database of 70 SPECT brain images yielding an accuracy up to 91.5% for a wide range of selected voxels.
Export Options
About this article
Cite this article as:
Salas-Gonzalez D., Segovia F., J. Martínez-Murcia F., W. Lang E., M. Gorriz J. and Ramırez J., An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease, Current Alzheimer Research 2016; 13 (7) . https://dx.doi.org/10.2174/1567205013666160415154852
DOI https://dx.doi.org/10.2174/1567205013666160415154852 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metabolic Reprogramming of Human Cells in Response to Oxidative Stress: Implications in the Pathophysiology and Therapy of Mitochondrial Diseases
Current Pharmaceutical Design Clearance of Genetic Variants of Amyloid β Peptide by Neuronal and Non-neuronal Cells
Protein & Peptide Letters Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease
Current Alzheimer Research Editorial (New Wave from Immunology, Endocrine & Metabolic Agents in Medicinal Chemistr )
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Curcumin: Structure-Activity Relationship Towards its Role as a Versatile Multi-Targeted Therapeutics
Mini-Reviews in Organic Chemistry Phosphodiesterase Inhibitors as Potential Cognition Enhancing Agents
Current Topics in Medicinal Chemistry Cannabinoids and Myocardial Ischemia: Novel insights, Updated Mechanisms, and Implications for Myocardial Infarction
Current Medicinal Chemistry New Treatments for COPD in the Elderly
Current Pharmaceutical Design Neuroimaging Findings Related to Behavioral Disturbances in Alzheimer's Disease: A Systematic Review
Current Alzheimer Research Chemical Composition and Biological Effects of Essential Oils from Some Aromatic and Medicinal Plants
The Natural Products Journal Mechanism of Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies
Current Alzheimer Research Pharmacological Intervention at Ionotropic Glutamate Receptor Complexes
Current Pharmaceutical Design Galanthum nivalis Extract is Neurologically Active and Improves Anxiety and Social Interactions in Mesocricetus auratus
The Natural Products Journal Oral Administration of the Food-Derived Hydrophilic Antioxidant Ergothioneine Enhances Object Recognition Memory in Mice
Current Molecular Pharmacology Associations between Periodontitis and Systemic Inflammatory Diseases: Response to Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance
Current Cancer Drug Targets Molecular Dynamics and Regulation of Butyrylcholinesterase Cholinergic Activity by RNA Binding Proteins
CNS & Neurological Disorders - Drug Targets Transcranial Magnetic Stimulation of Degenerating Brain: A Comparison of Normal Aging, Alzheimer’s, Parkinson’s and Huntington's Disease
Current Alzheimer Research Alzheimer's Disease-Like Pathologies and Cognitive Impairments Induced by Formaldehyde in Non-Human Primates
Current Alzheimer Research Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued)